The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypotheses
The investigators hypothesize that among individuals who suffer from panic disorder there is higher incidence of co-morbid balance impairment than in the healthy population.
The investigators hypothesize that the treatment of panic disorder, through the treatment of co-morbid balance impairment using virtual reality (VR) exposure therapy environment, is more effective than the exposure to still pictures from the same scene in VR without balance challenge or comparing to standard cognitive behavioral therapy (CBT) for the treatment of panic disorder.
Rationale
This research relies on previous studies, which have shown mutuality between anxiety and balance impairment, even if only sub-clinical. The VR-based training environment enables multi-sensorial stimulus in a dynamic interactively changing setting. With the addition of a cognitive task (dual task distracting the fear), the investigators can add cognitive load and therefore challenge the control of balance even more. Individuals who suffer from balance impairment avoid their exposure to many balance-challenging situations - a fact that may increase their anxiety. The investigators assume that a considerable number of PD individuals also experience balance control impairments - mostly subclinical ones. Moreover, balance impairment accompanies other psychiatric disorders, though not enough literature exists on the subject.
| Condition | Intervention |
|---|---|
|
Panic Disorder Proprioceptive Disorders |
Device: VR movie + balance challenge Device: still pictures from VR Behavioral: Cognitive Behavioral Therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Outcomes Assessor) Primary Purpose: Treatment |
- Change in Panic or anxiety levels [ Time Frame: weeks 1 (baseline) ,5 and 11 (end of trial) ] [ Designated as safety issue: No ]The investigators will evaluate panic and anxiety levels on week 1, and then examine whether there was a change in panic or anxiety levels on weeks 5 and 11.
- Change in Balance impairment [ Time Frame: weeks 1 (baseline) ,5 and 11 (end of trial) ] [ Designated as safety issue: No ]The investigators will evaluate balance impairment levels on week 1, and then examine whether there was a change in balance levels on weeks 5 and 11.
- blood pressure (mmHg) [ Time Frame: weeks 1 (baseline) ,5 and 11 (end of trial) ] [ Designated as safety issue: No ]The investigators will measure blood pressure on week 1 and then evaluate whether there was a change in blood pressure on weeks 5 and 11.
- heart rate (bpm) [ Time Frame: weeks 1 (baseline) ,5 and 11 (end of trial) ] [ Designated as safety issue: No ]The investigators will measure the heart rate on week 1 and then evaluate whether there was a change in heart rate on weeks 5 and 11.
| Estimated Enrollment: | 80 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: VR movie + balance challenge
VR-based balance training
|
Device: VR movie + balance challenge
Computer Assisted Rehabilitation Environment Integrated Reality System used for the challenge of balance control
Other Name: CAREN™ D-FLOW V 3.8.1 by MOTEK B.V
|
|
Sham Comparator: still pictures from VR
Exposure to still pictures from the same VR scene but no balance challenge
|
Device: still pictures from VR
Monitoring only still pictures from the VR scene in a loop, no balance challenge
Other Name: CAREN D-FLOW V 3.8.1 by MOTEK B.V.
|
|
Active Comparator: Cognitive Behavioral Therapy
Standard CBT protocol for the treatment of panic disorder
|
Behavioral: Cognitive Behavioral Therapy
For the treatment of panic disorder
Other Name: CBT standard protocol
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Stage 1
Patients
- Clinical diagnosis of panic disorder
- Stable on the same drug and dosage for at least one month
Healthy controls
- Determined as healthy upon completion of the MINI
- At the age of 18-45 years
- Matching patients by age, sex and BMI
Stage 2
Patients only
• The same patients, who have participated in Stage 1.
Exclusion Criteria:
Stage 1
Patients
- Co-morbidity with another psychiatric disorder (phobia is acceptable)
- Cognitive dysfunction or a neurological disorder
- Patients reacting with extreme anxiety to VR exposure at screening
- History of substance and/ or alcohol abuse
Healthy controls (in addition to the exclusion criteria above)
• Any psychiatric diagnosis
Stage 2
Patients only
The same patients from Stage 1, therefore they follow the same exclusion criteria mentioned in Stage 1.
Contacts and Locations| Contact: Revital Amiaz, MD | 972-3-5303774 | amiazr@gmail.com |
| Contact: Efrat Czerniak, MSc | 972-54-7711222 | efrat30.3@gmail.com |
| Israel | |
| Sheba Medical Center, Sheba Rehabilitation Center for Advanced Technologies | Not yet recruiting |
| Ramat Gan, Israel, 52621 | |
| Principal Investigator: Asaf Caspi, MD | |
| Sub-Investigator: Revital Amiaz, MD | |
| Principal Investigator: | Asaf Caspi, MD | Sheba Medical Center |
| Study Chair: | Matti Mintz, PhD | Tel Aviv University |
| Study Director: | Revital Amiaz, MD | Sheba Medical Center |
More Information
No publications provided
| Responsible Party: | Sheba Medical Center |
| ClinicalTrials.gov Identifier: | NCT01677429 History of Changes |
| Other Study ID Numbers: | SHEBA-12-9520-AC-CTIL |
| Study First Received: | August 19, 2012 |
| Last Updated: | September 30, 2012 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by Sheba Medical Center:
|
panic disorder balance impairment virtual reality |
Additional relevant MeSH terms:
|
Panic Disorder Somatosensory Disorders Anxiety Disorders Mental Disorders |
Sensation Disorders Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013